The largest database of trusted experimental protocols

Mar1 5a3 ifnar neutralizing antibody

Manufactured by BioXCell

MAR1–5A3 is an interfereron alpha/beta receptor (IFNAR) neutralizing antibody. It binds to the IFNAR and blocks the type I interferon signaling pathway.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using mar1 5a3 ifnar neutralizing antibody

1

Myocardial Infarction in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were intubated and ventilated with 2% isoflurane. After exposing the heart via thoracotomy at the fourth left intercostal space, the left coronary artery was permanently ligated with an 8–0 nylon monofilament suture. The thorax was closed with a 5–0 suture. Mice were treated with buprenorphine for analgesia on the day of surgery and twice daily thereafter for 72 hours. For cardioprotection experiments, mice were treated with two intraperitoneal doses of 500 μg of MAR1–5A3 IFNAR neutralizing antibody (BioXCell) at 8–12 hours and at 48 hours after permanent coronary ligation. Surgeries were performed in a blinded fashion unless genotype was obviated by unavoidable ascertainment of features such as coat color.
+ Open protocol
+ Expand
2

SARS-CoV-2 Infection Study in K18-hACE2 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the B6/JGpt-H11em1Cin(K18-ACE2)/Gpt mice (K18-hACE2 KI mice, heterozygote, #T037657) were obtained from GemPharmatech Co., Ltd. (Nanjing, China) and were maintained in individually ventilated cages (IVCs) in ABSL-II (AUP # SKLV-AE2023-007). The 6- to 8-week-old mice were infected via intranasal route with indicated Lentivirus, and then were weighed and monitored daily. In subsequent experiments, 14 days after Lentivirus-N transduction, mice were intranasally inoculated with 4 × 106 TCID50 of SARS-CoV-2 trVLPs, and the weights of mice were monitored daily. Mice were sacrificed at 2, 4, 6, 9 dpi for tissue processing. For experiments of IFNAR neutralizing antibody treatment, mice received two intraperitoneal injections of 1 mg of MAR1–5A3 IFNAR neutralizing antibody (BioXCell), both 24 h before and 24 h after trVLPs infection. All experiments were made to minimize animal suffering and have been approved by an ethical committee.
+ Open protocol
+ Expand
3

Myocardial Infarction in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were intubated and ventilated with 2% isoflurane. After exposing the heart via thoracotomy at the fourth left intercostal space, the left coronary artery was permanently ligated with an 8–0 nylon monofilament suture. The thorax was closed with a 5–0 suture. Mice were treated with buprenorphine for analgesia on the day of surgery and twice daily thereafter for 72 hours. For cardioprotection experiments, mice were treated with two intraperitoneal doses of 500 μg of MAR1–5A3 IFNAR neutralizing antibody (BioXCell) at 8–12 hours and at 48 hours after permanent coronary ligation. Surgeries were performed in a blinded fashion unless genotype was obviated by unavoidable ascertainment of features such as coat color.
+ Open protocol
+ Expand
4

Myocardial Infarction in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were intubated and ventilated with 2% isoflurane. After exposing the heart via thoracotomy at the fourth left intercostal space, the left coronary artery was permanently ligated with an 8–0 nylon monofilament suture. The thorax was closed with a 5–0 suture. Mice were treated with buprenorphine for analgesia on the day of surgery and twice daily thereafter for 72 hours. For cardioprotection experiments, mice were treated with two intraperitoneal doses of 500 μg of MAR1–5A3 IFNAR neutralizing antibody (BioXCell) at 8–12 hours and at 48 hours after permanent coronary ligation. Surgeries were performed in a blinded fashion unless genotype was obviated by unavoidable ascertainment of features such as coat color.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!